Cizumab Bevacizumab Injection - Sterile Vial, Injectable Solution, 1 Year Shelf Life | Anti-angiogenic, Multi-oncology Indications, Store 2-8â°c

Cizumab Bevacizumab Injection is a high-quality, targeted monoclonal antibody formulation used in the treatment of various types of cancers. It works by inhibiting vascular endothelial growth factor (VEGF), thereby preventing the formation of new blood vessels that tumors need to grow and spread.

This injection is widely prescribed as part of combination therapy for conditions such as metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and certain gynecological cancers. Manufactured under stringent quality standards, Cizumab ensures safety, efficacy, and consistent performance.

Key Features:

• Contains Bevacizumab as the active ingredient
• Anti-angiogenic action to restrict tumor growth
• Used in multiple oncology indications
• High purity and clinically proven formulation
• Manufactured in WHO-GMP compliant facilities

Packaging Details:

• Available in sterile vial form
• Different strengths available as per requirement
• Secure, tamper-proof packaging

Usage:

• Administered intravenously under the supervision of a qualified healthcare professional
• Dosage and duration depend on the patient's condition and medical history

Storage:

• Store in a refrigerator (2C to 8C)
• Do not freeze